🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great talk by John Chang on the role of CD8 Trm cells in IBD. Interesting overlap with what is seen in immune checkpoint colitis. #DDW2022

End of the year event for the terrific Stanbury Physician-Scientist Pathway at MGH IM Residents MassGeneral Medicine Caroline Sokol MDPhD

It was a real pleasure talking to my friend Kelsey on her new podcast Going on 30! We chatted about the journey to the US as an #IMG, medical training, and impostor syndrome. Link: podcasts.apple.com/us/podcast/goi… instagram.com/p/CeRKLNquho6/…

I really tried to cancel reading data. I tried hard MGH IM Residents. Appreciate the shout out Emily Moin! Congratulations on finishing residency!!

Thank you MGH IM Residents for a wonderful birthday celebration with a cake featuring my favorite pathway, NF-kB. It was the honor of my life working with all of you!

Thank you to MGH IM Residents for the roast at the annual Change Show and to Dr. Glaucomflecken for the shout out! Quite the guest appearance!!

A big win for OU Health! My good friend Mubeen Shakir going back home where I’m sure he will do great things!

Bevacizumab for persistent Heyde after SAVR/TAVR. It was great working with Zain Virk, Andrew Song and Hanny Al-Samkari, MD on this MGH Division of Gastroenterology

Incredible crew! Welcome to MGH Division of Gastroenterology

Great science and insights into MIS-C pathogenesis once again highlighting the importance of collaborative science that Casanova Lab does!

I threw Bard a curveball!

Somatic mosaicism is emerging as a new frontier in genomics. NIH has invested $140M to deeply characterize genomes across and within individuals. Really excited to co-lead Broad Institute's effort with Kristin Ardlie Niall J Lennon! nih.gov/news-events/ne… #SMaHTConsortium

Incredible to see how different the dominant negative RELA phenotype is from our first report of RELA haploinsufficiency back in 2017 rupress.org/jem/article/21… beautiful work Satoshi Okada Casanova Lab

We report here the safety of using infliximab or vedolizumab concurrently with immune checkpoint therapy in patients with prior immune-checkpoint colitis ⭐️Recurrent severe colitis (20.8% (IFX or Vedo) vs 34.4% (control) jitc.bmj.com/content/11/6/e…

Great working with you on this David Faleck Memorial Sloan Kettering Cancer Center MD Anderson Cancer Center !

New #JITC article: Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis bit.ly/3JyykyG Yousef Badran

Great news for Versanis and Aditum bio!

Thank you for your leadership through the years Jatin M. Vyas, MD, PhD. You are an exemplary physician, scientist, and mentor that we all aspire to emulate. I’m honored that I’ve had the chance to work with and learn from you. You will be missed!